Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

102.12 +1.41 (+1.39%)
Streaming Delayed Price Updated: 10:35 AM EST, Feb 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
8 Analysts Have This to Say About Boston Scientific
Via Benzinga
Why Boston Scientific Shares Are Trading Higher Today
Via Benzinga
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Thermo Fisher Pops On Its Bullish Outlook As Boston Scientific Gains On Its In-Line Report
Thermo Fisher provided a bullish outlook, while Boston Scientific's profit view was short. 
Via Investor's Business Daily
GE Healthcare Technology: Speculating On Dividends
GE Healthcare released a solid report and gave steady guidance that includes ample room in the cash flow for a dividend, should the board choose to pay one. 
Via MarketBeat
BOSTON SCIENTIFIC INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Boston Scientific Corporation - BSX
From Kahn Swick & Foti, LLC
Via Business Wire
4 Analysts Have This to Say About Boston Scientific
Via Benzinga
What 4 Analyst Ratings Have To Say About Boston Scientific
Via Benzinga
Expert Ratings for Boston Scientific
Via Benzinga
Boston Scientific's Return on Invested Capital Insights
Via Benzinga
Earnings Scheduled For February 1, 2023
Companies Reporting Before The Bell • Novo Nordisk (NYSE:NVO) is expected to report quarterly earnings at $0.85 per share on revenue of $6.84 billion. 
Via Benzinga
A Preview Of Boston Scientific's Earnings
Via Benzinga
Golden Cross Appears Before Boston Scientific Investors
Via Benzinga
Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects
Psychedelics biotech Clearmind Medicine Inc. (NASDAQ: CMND) has successfully completed two drug discovery projects with leading scientists at the Hebrew University of Jerusalem. 
Via Benzinga
How Doug Godshall Ignited The Spark At Shockwave
ShockWave Medical CEO Doug Godshall says successful companies don't follow a formula. 
Via Investor's Business Daily
Is Medtronic Stock Ready to Revive?
The world’s largest medical device maker Medtronic PLC (NYSE: MDT) stock has fallen since April 2022. However, shares may have bottomed out. 
Via MarketBeat
Topics Economy
Exposures Interest Rates Supply Chain
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
Via Benzinga
2 Smartest Tech Stocks to Buy in 2022 and Beyond
The tech space is still bursting with opportunities for long-term investors. 
Via The Motley Fool
Week In Review: Boston Scientific Pays $523 Million For Majority Stake In Beijing Acotec Scientific
Boston Scientific will pay $523 million for a 65% stake in Acotec Scientific, a Beijing medical device company. Boston Scientific said the acquisition will build up its presence in China, and it will... 
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Stocks To Eye This Week
In this week's video update, I provide technical analysis of various stocks to look into in the coming week. 
Via Talk Markets
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)
From Brodsky & Smith LLC
Via GlobeNewswire
Investors Liked These 2 Stock Buyouts Tuesday
Market performance was mixed as investors prepared for more insight on interest rates. 
Via The Motley Fool
Apollo Endosurgery (NASDAQ: APEN) Enters Into Agreement to be Acquired by Boston Scientific (NYSE: BSX) for $615 Million
Apollo Endosurgery, Inc. (NASDAQ: APEN) is a medical technology company, which is focused on the research and development of advanced, 
Via Spotlight Growth
Exposures Product Safety
Apollo Endosurgery (APEN) Stock Soars 65% on Boston Scientific Deal
Apollo Endosurgery is about to be acquired by Boston Scientific. Here's what this new deal means for BSX and for APEN stock. 
Via InvestorPlace
Scotts Miracle-Gro, Walgreens Boots Alliance And 2 Other Stocks Insiders Are Selling
US crude oil futures traded higher this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
S&P 500 Component DexCom Set For Further Price, Earnings Growth
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023. 
Via MarketBeat
Topics Stocks
Exposures US Equities
Edwards Life Sciences Stock Disaster Could Be Your Bounty
Heart disease equipment maker Edwards Life Sciences (NYSE: EW) stock has fallen (-46%) on the year after a disastrous reaction to its Q3 2022 earnings report. 
Via MarketBeat
Topics Death
Exposures COVID-19 Death
Intuitive Surgical Stock is Both a Legacy and Next-Gen Play
It’s hard to believe that the da Vinci Surgical System developed by Intuitive Surgical (NASDAQ: ISRG) is turning 22 years old since its U.S. Food and Drug 
Via MarketBeat
Topics Economy
Exposures COVID-19 Interest Rates Supply Chain
This Congresswoman Is Selling Energy Stocks, But Purchased These 2 Dividend Paying Retailers
Congresswoman Lois Frankel (D-FL) made more than 430 trades in the past three years, which are typically filed in the range of $1,000 to $15,000 in shares, according to Capitol Trades. 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.